Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lumiracoxib in Knee OA or RA
NCT00170872Phase 3Completed
- Sponsor
- Novartis
- Start
- Nov 2004
- Primary completion
- Jul 2005
- Modality
- Small Molecules
01
Overview
Phase 3, open-label, single-arm trial of lumiracoxib in osteoarthritis (OA) and rheumatoid arthritis (RA), sponsored by Novartis. Primary endpoint: Safety and Tolerability Profile. Started Nov 2004; status: completed.
02
Drugs
lumiracoxib
03
Conditions
osteoarthritis (OA)rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT00170872.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00170872.